BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park J, Lee IS, Kim KH, Kim Y, An EJ, Jang HJ. GI inflammation Increases Sodium-Glucose Cotransporter Sglt1. Int J Mol Sci 2019;20:E2537. [PMID: 31126070 DOI: 10.3390/ijms20102537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Coras R, Murillo-Saich JD, Guma M. Circulating Pro- and Anti-Inflammatory Metabolites and Its Potential Role in Rheumatoid Arthritis Pathogenesis. Cells 2020;9:E827. [PMID: 32235564 DOI: 10.3390/cells9040827] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
2 Itoh H, Tanaka M. “Greedy Organs Hypothesis” for sugar and salt in the pathophysiology of non-communicable diseases in relation to sodium-glucose co-transporters in the intestines and the kidney. Metabolism Open 2022. [DOI: 10.1016/j.metop.2022.100169] [Reference Citation Analysis]
3 Hong JH, Kim DH, Lee MK. Glucolipotoxicity and GLP-1 secretion. BMJ Open Diabetes Res Care 2021;9:e001905. [PMID: 33627316 DOI: 10.1136/bmjdrc-2020-001905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang X, Guo K, Huang B, Lin Z, Cai Z. Role of Glucose Transporters in Drug Membrane Transport. Curr Drug Metab 2020;21:947-58. [PMID: 32778021 DOI: 10.2174/1389200221666200810125924] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun Z, Chai Q, Zhang Z, Lu D, Meng Z, Wu W. Inhibition of SGLT1 protects against glycemic variability-induced cardiac damage and pyroptosis of cardiomyocytes in diabetic mice. Life Sci 2021;271:119116. [PMID: 33508297 DOI: 10.1016/j.lfs.2021.119116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]